Skip to main content

Topic

Pediatric Formulations

1 published work

  1. Big Molecule Watch

    FDA Approves Celltrion’s New Pediatric Formulation of STEQEYMA, Expanding Dosing Flexibility

    By Yoko Bian

    On June 15, 2025, Celltrion announced that the FDA has approved a new 45mg/0.5mL single-dose vial presentation of STEQEYMA (ustekinumab-stba) for subcutaneous injection.  The formulation is intended for pediatric patients…